HPV-based cervical cancer screening in a population at high risk for HIV infection

International Journal of Cancer

Volumn 85, Issue 2, 2000, Pages 206-210

  Womack, Sharita D ^a   Chirenje, Z Michael ^b   Gaffikin, Lynne ^c   Blumenthal, Paul D ^d   McGrath, John A ^c   Chipato, Thomas ^b   Ngwalle, Stephen ^b   Munjoma, Marshall ^b   Shah, Keerti V ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^c JHPIEGO   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS PATHOGENESIS; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV; HIV INFECTIONS; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; ZIMBABWE;

EID: 0034650926     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000115)85:2<206::AID-IJC10>3.0.CO;2-Q     Document Type: Article

References (26)

1. BASSETT, M.T., CHOKUNOGNA, E., MAUCHAZA, B., LEVY, L., FERLAY, J. and PARKIN, D.M., Cancer in the African population of Harare, Zimbabwe 1990-1992. Int. J. Cancer, 63, 29-36 (1995).
2. BOSCH, F.X., MANOS, M.M., MUNOZ, N., SHERMAN, M. JJANSEN, A.M., PETO, J., SCHIFFMAN, M.H., MORENO, V., KURMAN, R. and SHAH, K.V., Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J. nat. Cancer Inst., 87, 796-802 (1995).
3. CHOI B.C.K., Sensitivity and specificity of a single diagnostic test in the presence of work-up bias. J. clin. Epidemiol., 45, 581-586 (1992).
4. CUZICK, J., SZAREWSKI, A., TERRY, G., Ho, L., HANBY, A., MADDOX, P., ANDERSON, M., KOCYAN, G., STEELE, S.T. and GUILLEBAUD J., Human papillomavirus testing in primary cervical cancer screening. Lancet, 345, 1533-1536 (1995).
5. DEL PRIORE, G. and LURAIN, J., The value of cervical cytology in HIV-positive women. Gynecol. Oncol., 56, 395-398 (1995).
6. FINK, M.J., FRUCHER, R.G., MAIMAN, M., KELLY, P., SEDLIS, A., WEBBER, C. A. and CHEN, P., The adequacy of cytology and colposcopy in diagnosing cervical neoplasia in HIV-seropostive women. Gynecol. Oncol., 55, 133-137 (1994).
7. HERRERO, R., SCHIFFMAN, M.H., BRATTI, C., HILDESHEIM, A., SHERMAN, M., MORALES, J., MEKBEL, S., ALFARO, M., BALMACEDA, I., GREENBERG, M., LORINCZ, A., Evaluation of multiple screening techniques in a high risk area: the Guanacaste Project. In: E.L. Franco and J. Monsonego, (eds.), New developments in cervical cancer screening and prevention, pp. 389-399, Blackwell, Oxford (1997).
8. KORN, A., AUTRY, M. and DEREMER P., Sensitivity of the Papanicolaou smear in human immunodeficiency virus infected women. Obstet. Gynecol., 83, 401-404 (1994).
9. KREISS, J.K., KIVIAT, N.B., PLUMMER, F.A., ROBERTS, P.L., WWIYAKI, P., NGUGI, E. and HOLMES, K.K., Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes. Sex. Trans. Dis., 19, 54-59 (1992).
10. LORINCZ, A.T., Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens. Papillomavirus Report, 7, 1-5 (1996).
11. LORINCZ, A.T., HILDESHEIM, A., HERRERO, R., MIELZYNSKA, I. and SHERMAN, M.E., Comparison of Hybrid Capture II HPV DNA detection and conventional Pap smear for cervical cancer screening in Costa Rica. 17th International Papillomavirus Conference (Abstract), (1999).
12. MAIMAN, M., TARRICONE, N., VIEIRA, J., SUAREZ, J., SERUR, E. and BOYCE, J.G., Colposcopic evaluation of human immunodeficiency virus seropositive women. Obstet. Gynecol., 78, 84-88 (1991).
13. MANDELBLATT, J.S., FAHS, M., GARIBALDI, K., SENIE, R.T. and PETERRSON H.B., Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions. AIDS, 6, 173-178 (1992).
14. MEIJER, C.J., VAN DER BRULE, A.J., SNIJDERS, P.J., HELMERHORST, T., KENEMANS, P. and WALLBOOMERS, J.M., Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening. In: N. Munoz, F.X. Bosch, K.V. Shah and A. Meheus, (eds.), The epidemiology of human papillomavirus and cervical cancer, IARC Sci. Publ., 119, 271-281 (1992).
15. OLAITIN, A., MOCROFT, A., PHILLIPS, A., REID, W. and JOHNSON, M., Cervical pathology and sexually transmitted disease screening in human immunodeficiency virus-positive women. Obstet. Gvnecol., 89, 71-75 (1997).
16. SCHNEIDER, A. and KOUTSKY, L., Natural history and epidemiological features. In: N. Munoz, F.X. Bosch, K.V. Shah and A. Meheus, (eds.), The epidemiology of human papillomavirus and cervical cancer, IARC Sci. Publ., 119, 23-52 (1992).
17. SCHNEIDER, A., ZAHM, D.M., KIRCHMAYR, R. and SCHNEIDER, V., Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography and human papillomavirus detection. Amer. J. Obstet. Gynecol., 174, 1534-1541 (1996).
18. SUN, X.W., ELLERBROCK, T.V., LUNGU, O., CHAISSON, M.A., BUSH, T.J. and WRIGHT, T.C., Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet. Gynecol., 85, 680-686 (1995).
19. TWEDDEL, G., HELLER, P., CUNNANE, M., MULTHAUPT, H. and ROTH, K., The correlation between HIV seropositivity, cervical dysplasia and HPV subtypes 6/11, 16/18, 31/33/35. Gynecol. Oncol., 52, 161-164 (1994).
20. UNAIDS/WHO, Working group on global HIV/AIDS and STD and AIDS surveillance: epidemiological fact sheet on HIV/AIDS and STDs. UNAIDS/ WHO, Geneva (1997).
21. UNIVERSITY OF ZIMBABWE/JHPIEGO CERVICAL CANCER PROJECT, Visual inspection with acetic acid for cervical cancer screening: test qualities in a primary care setting. Lancet. 353, 869-873 (1999).
22. VERMUND, S.H., KELLEY, K.F., KLEIN, R.S., FEINGOLD, A.R., SCHREIBER, K., MUNK, G. and BORK, R.D., High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Amer. J. Obstet. Gynecol., 165, 392-400 (1991).
23. WAWER, M.J. and 14 OTHERS, Control of sexually transmitted disease for AIDS prevention in Uganda: a randomized community trial. Lancet, 353, 525-535 (1999).
24. WOMACK, S.D., CHIRENJE, Z.M., BLUMENTHAL, P.D., GAFFIKIN, L., MCGRATH, J.A., CHIPATO, T., NGWALLE, E. and SHAH, K.V., Evaluation of a human papillomavirus (HPV) assay in cervical cancer screening in Zimbabwe. Brit. J. Obstet. Gynecol., (1999). (In press).
25. WRIGHT, T.C., ELLERBROCK, T.V., CHAISSON, M.E., SUN, X. and VANDERVANTER, N., Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors and validity of Papanicolaou smear. Obstet. Gynecol., 84, 591-597 (1994).
26. ZIMBABWE MINISTRY OF HEALTH AND CHILD WELFARE, Report of an HIV/STD and AIDS surveillance workshop. Health Information Unit, Zimbabwe Ministry of Health and Child Welfare, Harare, Zimbabwe (1994).